Live Breaking News & Updates on Valneva initiate phase

Stay updated with breaking news from Valneva initiate phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates -September 21, 2023 at 01:01 am EDT

 Product sales more than doubled in the first half of 2023 to €69.7 million compared to €33.3 million in the first half of 2022 Driven by IXIARO® and DUKORAL® sales, both of which benefited. ....

Canada , United-states , Sweden , New-zealand , France , Thailand , United-kingdom , Switzerland , Australia , Solna , Stockholm , Japan

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , New-york , America , Annaliesa-anderson , Juan-carlos-jaramillo , Lyme-borreliosis , Joshua-drumm , European-medicines-agency , Youtube , Head-vaccine-research , Pfizer-inc , Centers-for-disease

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate

07.09.2023 - Strong immune response shown in both children and adolescents one month after booster dose (month 19) in VLA15-221 studyPreviously observed high anamnestic antibody response in adults confirmedVLA15 well-tolerated in all age groups following booster . ....

United-states , America , Lyme-borreliosis , Juan-carlos-jaramillo , Annaliesa-anderson , Joshua-drumm , National-surveillance-systems , Youtube , Head-vaccine-research , Drug-administration , Pfizer , Centers-for-disease

VALNEVA: Valneva Reports Full Year 2022 Results and Provides Corporate Updates

Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales ....

Japan , Finland , Australia , Thailand , France , New-zealand , Sweden , United-kingdom , United-arab-emirates , Denmark , Austria , Germany